Pathologically examining a minimum of three lymph nodes could better determine node negativity in patients with non-metastatic chromophobe renal cell carcinoma.

作者: Fan Dong , Liqi Xu , Xiaoqiong Peng , Tianyuan Xu , Yifan Shen

DOI: 10.1093/JJCO/HYY121

关键词: MedicineUrologyChromophobe Renal Cell CarcinomaLymphadenectomyMultivariate analysisDissectionProportional hazards modelLymph nodeMetastasisNephrectomy

摘要: Objective To evaluate the prognostic value of lymph node (LN) involvement for patients with chromophobe renal cell carcinoma (chRCC) and ascertain minimum number LNs that need to be pathologically examined reliably diagnose a patient negative chRCC. Methods From 2004 2014, non-metastatic chRCC receiving radical nephrectomy together lymphadenectomy were identified from Surveillance, Epidemiology End Results (SEER) database. The primary outcome was overall survival (OS). Two hundred forty-six received dissection during surgery. Of patients, 24 (10%) had confirmed positive LN. Multivariate Cox regression model showed LN an independent unfavorable predictor OS (HR = 2.83, 95%CI 1.14-6.98, P 0.024). More importantly, LN(-) at least three dissected significantly better compared when 1-2 (P 0.048). analysis in examination or more could independently predict only (HR≥3LNs 0.362, 95% CI 0.135-0.972, 0.044). Additionally, likelihood finding one higher on ≥3 (15% vs 5%, 0.018). Decision curve found clinical validity '3 examined'-based classification traditional LN(-)/LN(+) classification. Conclusion proportion far neglectable metastasis OS. We recommended should order determine negative.

参考文章(27)
Alessandro Volpe, Giacomo Novara, Alessandro Antonelli, Roberto Bertini, Michele Billia, Giorgio Carmignani, Sergio Cosciani Cunico, Nicola Longo, Guido Martignoni, Andrea Minervini, Vincenzo Mirone, Alchiede Simonato, Carlo Terrone, Filiberto Zattoni, Vincenzo Ficarra, Surveillance and Treatment Update on Renal Neoplasms (SATURN) Project–Leading Urological No‐Profit Foundation for Advanced Research (LUNA) Foundation, None, Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series. BJUI. ,vol. 110, pp. 76- 83 ,(2012) , 10.1111/J.1464-410X.2011.10690.X
Monish Aron, Mike M Nguyen, Robert J Stein, Inderbir S Gill, None, Impact of Gender in Renal Cell Carcinoma: An Analysis of the SEER Database European Urology. ,vol. 54, pp. 133- 142 ,(2008) , 10.1016/J.EURURO.2007.12.001
Naoto Kuroda, Masato Tamura, Ondrej Hes, Michal Michal, Taro Shuin, Makoto Toi, Yoshihiro Hayashi, Gang-Hong Lee, Chromophobe renal cell carcinoma with prominent lymph node metastasis and polysomy of chromosome 21: poorly differentiated form or “presarcomatoid” form? Medical Molecular Morphology. ,vol. 44, pp. 168- 173 ,(2011) , 10.1007/S00795-009-0467-6
M. Golimbu, A. Tessler, P. Joshi, S. Al-Askari, A. Sperber, P. Morales, Renal cell carcinoma: Survival and prognostic factors Urology. ,vol. 27, pp. 291- 301 ,(1986) , 10.1016/0090-4295(86)90300-6
Patrick E. Teloken, R. Houston Thompson, Satish K. Tickoo, Angel Cronin, Caroline Savage, Victor E. Reuter, Paul Russo, Prognostic Impact of Histological Subtype on Surgically Treated Localized Renal Cell Carcinoma Journal of Urology. ,vol. 182, pp. 2132- 2136 ,(2009) , 10.1016/J.JURO.2009.07.019
Mahul B. Amin, Gladell P. Paner, Isabel Alvarado-Cabrero, Andrew N. Young, Hans J. Stricker, Robert H. Lyles, Holger Moch, Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases. The American Journal of Surgical Pathology. ,vol. 32, pp. 1822- 1834 ,(2008) , 10.1097/PAS.0B013E3181831E68
Stefan Zastrow, Sabine Brookman-May, Thi Anh Phuong Cong, Stanislaw Jurk, Immanuel von Bar, Vladimir Novotny, Manfred Wirth, Decision curve analysis and external validation of the postoperative Karakiewicz nomogram for renal cell carcinoma based on a large single‑center study cohort World Journal of Urology. ,vol. 33, pp. 381- 388 ,(2015) , 10.1007/S00345-014-1321-6
Jared M. Whitson, Catherine R. Harris, Adam C. Reese, Maxwell V. Meng, Lymphadenectomy Improves Survival of Patients With Renal Cell Carcinoma and Nodal Metastases The Journal of Urology. ,vol. 185, pp. 1615- 1620 ,(2011) , 10.1016/J.JURO.2010.12.053
John C. Cheville, Christine M. Lohse, Horst Zincke, Amy L. Weaver, Michael L. Blute, Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. The American Journal of Surgical Pathology. ,vol. 27, pp. 612- 624 ,(2003) , 10.1097/00000478-200305000-00005